Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K042945
    Device Name
    AURA CPAP SYSTEM
    Manufacturer
    Date Cleared
    2005-03-09

    (135 days)

    Product Code
    Regulation Number
    868.5905
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    AURA CPAP SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The aura CPAP System provides continuous positive airway pressure (CPAP) to support treatment of adults (over 30kg) with Obstructive Sleep Apnea.

    Device Description

    The aura CPAP System provides a continuous positive airway pressure (CPAP) to support treatment of obstructive sleep apnea. During obstructive sleep apnea, the airway collapses. When interfaced with a CPAP Mask or CPAP Patient Interface the aura CPAP System provides a constant pressure of 4 to 20 cmH2O above the ambient atmospheric pressure to patient's nasal airway. This constant pressure supports retaining an open airway during sleep.

    The aura CPAP System has four significant components:

      1. CPAP Blower,
      1. Optional Humidifier,
      1. Optional Battery Pack, and
      1. Patient Interface.
    AI/ML Overview

    The provided document describes the AEIOMed aura CPAP System, a device intended for the treatment of obstructive sleep apnea. However, it does not contain detailed information about specific acceptance criteria or a study that rigorously proves the device meets those criteria in the way typically expected for a detailed scientific or clinical study.

    Instead, the document is a 510(k) premarket notification summary, which focuses on demonstrating substantial equivalence to existing legally marketed predicate devices. The "Summary of Safety and Effectiveness" section and the FDA letter confirm this.

    Therefore, many of the requested data points (like sample size for test sets, number of experts for ground truth, MRMC studies, standalone performance, detailed ground truth methods, training set details) are not available in this specific document, as those are generally associated with more extensive clinical trials or performance studies that were likely not required for a 510(k) submission based on substantial equivalence and laboratory testing.

    Here's what can be extracted and what is missing:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Not explicitly stated in terms of numerical performance targets (e.g., specific pressure accuracy, flow rates across different conditions).The device "provides a constant pressure of 4 to 20 cmH2O above ambient atmospheric pressure to patient's nasal airway." This is a functional description, not a performance metric against a defined criterion.
    Substantial equivalence to predicate devices (BREAS PV10 CPAP System, Respironics REMstar Plus CPAP System).Conclusion: "The aura CPAP System is substantially equivalent to the predicate devices. Laboratory and standards compliance were provided to support the aura CPAP System performance."
    Compliance with relevant laboratory and safety standards."Laboratory and standards compliance were provided..." (details of which standards and specific compliance data are not included in this summary).

    2. Sample size used for the test set and the data provenance

    • Not explicitly stated/Provided. The document refers to "Laboratory and standards compliance" but does not detail a clinical test set with human subjects. The evaluation for 510(k) substantial equivalence often relies on bench testing, electrical safety, and biocompatibility rather than extensive clinical studies if the technology is well-established and has predicate devices.
    • Data Provenance: Not specified, but given it's a US company seeking FDA clearance, any supporting data would likely adhere to US regulatory standards.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Not applicable/Provided. This type of detail is absent because the submission focuses on substantial equivalence and laboratory testing, not a clinical study requiring expert ground truth for interpretation of outcomes.

    4. Adjudication method for the test set

    • Not applicable/Provided. No clinical test set with adjudicated outcomes is described.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • No. This is not an AI-assisted device. It's a medical device (CPAP system) for delivering continuous positive airway pressure. Therefore, an MRMC study related to AI assistance is irrelevant.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not applicable. This question pertains to algorithmic performance, which is not relevant to a mechanical CPAP device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    • Not applicable. For this type of device and submission, the "ground truth" would be related to engineering specifications, safety standards, and performance characteristics demonstrated through bench testing, rather than clinical outcomes or diagnoses. The device's ability to maintain a prescribed pressure and operate safely and effectively as designed would be the focus.

    8. The sample size for the training set

    • Not applicable/Provided. There is no indication of a "training set" in the context of machine learning or AI, as this is a mechanical medical device.

    9. How the ground truth for the training set was established

    • Not applicable/Provided. As above, no training set or machine learning components are mentioned.

    In summary: The document is a 510(k) clearance summary, which primarily aims to demonstrate substantial equivalence to existing devices through appropriate testing (likely bench testing and compliance with relevant standards) rather than extensive de novo clinical trials with human subjects and expert adjudication of outcomes. Therefore, much of the requested information related to clinical study design and performance metrics against specific, numerically defined acceptance criteria is not present here. The main "acceptance criterion" presented is substantial equivalence, which the FDA concurred with.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1